BSE Live
Nov 11, 16:01Prev. Close
5146.20
Open Price
5140.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 11, 15:46Prev. Close
5140.00
Open Price
5138.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
4997.00 (1)
| Cash Flow of Pfizer (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 1,016.09 | 746.07 | 824.01 | 772.89 | 668.72 | |
| Net CashFlow From Operating Activities | 659.75 | 256.84 | 355.68 | 667.08 | 427.33 | |
| Net Cash Used In Investing Activities | -71.34 | 53.70 | -36.05 | -575.02 | -468.84 | |
| Net Cash Used From Financing Activities | -205.34 | -235.14 | -345.79 | -180.51 | -1,571.07 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 383.07 | 75.40 | -26.16 | -88.45 | -1,612.58 | |
| Cash And Cash Equivalents Begin of Year | 112.00 | 36.60 | 62.76 | 151.21 | 1,763.79 | |
| Cash And Cash Equivalents End Of Year | 495.07 | 112.00 | 36.60 | 62.76 | 151.21 |
03.10.2025
Why Pfizer struck a drug-pricing deal with the Trump administration
01.10.2025
Trump unveils 'TrumpRx' website for cheaper drugs, Pfizer promises up to 50% discounts | Explained
22.09.2025
14.08.2025
20.05.2025
Pfizer Standalone March 2025 Net Sales at Rs 591.91 crore, up 8.28% Y-o-Y
01.02.2025
Pfizer Standalone December 2024 Net Sales at Rs 537.99 crore, down 0.37% Y-o-Y
30.07.2024
Pfizer Standalone June 2024 Net Sales at Rs 562.86 crore, up 5.93% Y-o-Y
20.05.2024
Pfizer Standalone March 2024 Net Sales at Rs 546.63 crore, down 4.54% Y-o-Y
19.10.2016
05.08.2016
03.01.2014
10.01.2011